Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid

1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid is listed in the pharmaceutical impurity collection under CAS 1696392-11-6. Its represented structure has formula C24H21N3O4 and a calculated molecular weight of 415.45 g/mol.

2D chemical structure

O N O O H N H 2 N O

Chemical identity

Catalog name
1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid
Common name
Not available
Chemical name
3-[[4-(2-carbamoylphenyl)phenyl]methyl]-2-ethoxy-benzimidazole-4-carboxylic acid
CAS
1696392-11-6
SMILES
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2C(N)=O)cc1
InChI
InChI=1S/C24H21N3O4/c1-2-31-24-26-20-9-5-8-19(23(29)30)21(20)27(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22(25)28/h3-13H,2,14H2,1H3,(H2,25,28)(H,29,30)
InChIKey
DEKJJZVBGQUKPQ-UHFFFAOYSA-N
Associated API
Azilsartan

Record ID: A1acbf28fa855

Computed properties

C24H21N3O4 Molecular formula
415.449 g/molMolecular weight
415.1532 DaMonoisotopic exact mass
107.44 ŲTopological polar surface area
3.9474 Calculated LogP (Wildman–Crippen)
117.3592 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight415.44972.74
Calculated LogP (Wildman–Crippen)3.947477.79
Topological polar surface area107.4476.17
Hydrogen-bond acceptors450.68
Hydrogen-bond donors264.87
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H21N3O4dimensionless
Molecular weight415.449g/mol
Monoisotopic exact mass415.1532Da
Topological polar surface area107.44Ų
Calculated LogP (Wildman–Crippen)3.9474dimensionless
Molar refractivity (Wildman–Crippen)117.3592cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors2count
Rotatable bonds (strict)7count
Heavy atoms31count
Heteroatoms7count
Rings4count
Aromatic rings4count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles3count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.125fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area178.2615Ų
Valence electrons156count
Radical electrons0count
Bertz complexity1,275.9791index
Balaban J1.7414index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid

Qualification and safety assessment of 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid

Explore toxicological qualification of 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid and ICH M7 mutagenic impurity assessment of 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid and acceptable intake and limit justification for 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-[(2'-Carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylic acid

Explore Altox services and software through the Altox Pharma-Hub.